WASHINGTON (dpa-AFX) - AbbVie (ABBV), a pharmaceutical company, announced on
Monday that Robert Michael has assumed the role of Chief Executive Officer and
has joined the Board with effect from July 1.

As announced earlier, Michael succeeds Richard Gonzalez, who has been appointed
as the Executive Chairman of the Board.

Michael previously served as Chief Operating Officer of AbbVie and has been a
longstanding member of AbbVie's Executive Leadership Team.



Copyright(c) 2024 RTTNews.com. All Rights Reserved

Copyright RTT News/dpa-AFX